CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
OPERATING ACTIVITIES
Net income including non-controlling interests	$ 32,175	$ 23,290
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:
Depreciation and amortization	4,958	4,866
Provision for doubtful accounts	2,446	2,212
Equity-based awards compensation expense	3,558	2,937
Deferred income taxes	5,421	(1,736)
Gain on sale of partnership interest, net of tax	(4,294)	0
Other	21	94
Changes in operating assets and liabilities:
Increase in patient accounts receivable	(4,956)	(2,141)
Increase in accounts receivable - other	(2,468)	(2,934)
Increase in other assets	(2,759)	(140)
(Decrease) increase in accounts payable and accrued expenses	(4,780)	4,845
Decrease in other liabilities	(701)	(672)
Net cash provided by operating activities	28,621	30,621
INVESTING ACTIVITIES
Purchase of fixed assets	(4,876)	(3,270)
Purchase of business	(18,239)	(9,118)
Purchase of redeemable non-controlling interest, temporary equity	(2,053)	0
Purchase of non-controlling interest, permanent equity	(138)	(245)
Proceeds on sale of fixed assets	65	1
Net cash used in investing activities	(25,241)	(12,632)
FINANCING ACTIVITIES
Distributions to non-controlling interests, permanent and temporary equity	(7,934)	(6,735)
Cash dividends paid to shareholders	(6,891)	(5,828)
Proceeds from revolving line of credit	80,000	55,000
Payments on revolving line of credit	(56,000)	(53,000)
Payments to settle mandatorily redeemable non-controlling interests	0	(265)
Principal payments on notes payable	(1,057)	(1,898)
Other	(7)	(48)
Net cash provided by (used in) financing activities	8,111	(12,774)
Net increase in cash and cash equivalents	11,491	5,215
Cash and cash equivalents - beginning of period	23,368	21,933
Cash and cash equivalents - end of period	34,859	27,148
Cash paid during the period for:
Income taxes	4,339	7,483
Interest	902	1,106
Non-cash investing and financing transactions during the period:
Purchase of business - seller financing portion	4,000	550
Purchase of business - payable to common shareholders of acquired business	502	0
Receivable related to sale of partnership interest	11,601	0
Payable related to purchase of partnership interest - settlement of redeemable non-controlling interest	2,200	0
Notes receivable related to sale of partnership interest - redeemable non-controlling interest	$ 2,780	$ 0